Eli Lilly to Buy 3 Vaccine Developers
Eli Lilly said on Tuesday that it would buy three vaccine developers in deals collectively worth up to $4 billion, a move that signals a return to an area that had not been a major focus for the company in recent years. The three are […]
Science & Environment
